Named on 13 rounds in the feed, most often at Series C and in Biotech.
Rounds from 2021-06-16 to 2026-11-05
ROUNDS
13
joined, none as lead
ROUNDS JOINED · USD
$1.7B
across 13 rounds
CO-INVESTORS
101
most often with Nextech Invest
Named on 13 rounds in the feed, most often at Series C and in Biotech.
Rounds from 2021-06-16 to 2026-11-05
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
T-Therapeutics A biotechnology company developing next-generation T cell receptor (TCR) T cell engager (TCE) therapeutics for cancer and autoimmune diseases | Series B Verified against 1 of 67 sources | $133M | 2026-11-05 | [ PART ] |
General Medicine A nationwide healthcare store where customers can search, compare, and buy care | Series B Verified against 1 of 19 sources | $120M | 2026-10-06 | [ PART ] |
BigHat Biosciences A clinical-stage, AI-driven protein therapeutics platform company | Series C Verified against 4 of 28 sources | $75M | 2026-09-23 | [ PART ] |
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series E Verified against 5 sources | $92.5M | 2026-09-16 | [ PART ] |
Thatch A health benefits platform that lets employers set health budgets so employees can choose their own insurance and healthcare services. | Series C Verified against 9 sources | $108M | 2026-09-15 | [ PART ] |
Remedium Bio A biotechnology company developing durable protein therapeutics | Series A Verified against 3 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $10M | 2026-08-09 | [ PART ] |
AdvanCell AdvanCell is developing targeted alpha radiotherapies for cancer. | Series D Verified against 4 of 6 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $315M | 2026-07-15 | [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series C Verified against 5 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $85M | 2026-06-30 | [ PART ] |
NewLimit NewLimit is extending human healthspan by unlocking regenerative potential., | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $435M | 2026-06-02 | [ PART ] |
SanegeneBio Innovative RNAi therapeutics for chronic diseases, targeting autoimmune, cardiovascular, obesity, and metabolic diseases for healthcare providers and researchers. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $110M | 2025-12-08 | [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $123M | 2023-03-22 | [ PART ] |
SonoThera SonoThera develops innovative ultrasound-mediated nonviral genetic therapies targeting various medical conditions. | Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $60.8M | 2022-12-05 | [ PART ] |
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series C Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $66M | 2021-06-16 | [ PART ] |